Related by context. Frequent words. (Click for all words.) 70 Secondary endpoints 64 Secondary endpoints included 61 hepatic function 61 receiving VELCADE 60 HMG CoA reductase inhibitors 60 lipid lowering agents 60 metabolic parameters 60 PREZISTA r 60 Montgomery Asberg Depression 59 Exclusion criteria 59 extrapyramidal symptoms 59 fasting insulin 59 Coadministration 59 erythrocyte sedimentation rate 59 fasting plasma glucose FPG 59 neutropenia thrombocytopenia 58 secondary efficacy endpoints 58 concomitant medications 58 APTIVUS r 58 Hematologic 58 J Am Coll 58 aspirin beta blockers 58 SIMCOR 58 secondary endpoints 58 pharmacokinetic parameters 58 Thrombolysis 58 thyroid stimulating hormone 58 coadministration 58 Secondary endpoints include 58 irbesartan 58 serum uric acid 57 serum potassium 57 Pharmacodynamic 57 pharmacodynamic effects 57 hypoglycemic events 57 hypercholesterolaemia 57 estimated glomerular filtration 57 posttreatment 57 HRQL 57 Visual Analog Scale 57 mucosal healing 57 abdominal ultrasound 57 Postoperative 57 Pioglitazone 57 Psoriasis Area 57 alanine aminotransferase 57 severe renal impairment 57 COPD exacerbations 57 Aprotinin 57 hypocalcemia 56 recurrent glioblastoma multiforme 56 lipid parameters 56 Health Assessment Questionnaire 56 Alzheimer Disease Assessment 56 TYSABRI treated 56 Generalized Anxiety Disorder 56 serum lipids 56 insulin detemir 56 efficacy endpoints 56 DLTs 56 multivariate logistic regression 56 APTIVUS 56 angina chest 56 neurocognitive function 56 Rating Scale MADRS 56 H2 blockers 56 TEAEs 56 metabolic acidosis 56 pharmacokinetics PK 55 Cognitive Impairment 55 adenotonsillectomy 55 univariate 55 Cognitive Function 55 hemoglobin A1c HbA1c 55 tissue perfusion 55 Randomized controlled 55 loop diuretics 55 lipid abnormalities 55 #mg/day [001] 55 NATRECOR R 55 creatine kinase 55 Withdrawal symptoms 55 CDAI 55 baseline HbA1c 55 fulvestrant 55 Endpoints 55 abdominal distension 55 μg kg 55 Tekamlo 55 Observational studies 55 non valvular atrial 55 olmesartan 54 Pediatric Patients 54 glomerular filtration rate 54 gallstone disease 54 Pharmacokinetic 54 Amiodarone 54 Celecoxib 54 Contraindications 54 dose titration 54 therapeutic regimens